1
|
Clua Provost C, Auboyer L, Rovelet-Lecrux A, Monzo C, Schob E, Andreux F, Quittet C, Lehmann S, Wallon D, Crozet C. Generation of induced pluripotent stem cell lines IRMBi003-A and IRMBi003-B from a healthy donor to model Alzheimer's disease. Stem Cell Res 2023; 73:103250. [PMID: 37979430 DOI: 10.1016/j.scr.2023.103250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/05/2023] [Revised: 10/24/2023] [Accepted: 11/10/2023] [Indexed: 11/20/2023] Open
Abstract
Induced Pluripotent Stem Cell (iPSC) lines derived from healthy individuals are helpful and essential tools for disease modelling. Here, we described the reprogramming of skin fibroblasts obtained from a healthy 59-year-old individual without Alzheimer's disease. The generated iPSC lines have a normal karyotype, expressed pluripotency markers, and demonstrated the ability to differentiate into the three germ layers. The iPSC lines will be used as controls to study Alzheimer's disease mechanisms.
Collapse
Affiliation(s)
- C Clua Provost
- Institute for Neurosciences of Montpellier, Univ Montpellier, INSERM U1298, Montpellier, France
| | - L Auboyer
- Institute for Regenerative Medicine and Biotherapy (IRMB), Univ Montpellier, INSERM, CHU Montpellier, Montpellier, France
| | - A Rovelet-Lecrux
- Normandie Univ, UNIROUEN, INSERM U1245, Rouen University Hospital, Department of Genetics and CNR-MAJ, Normandy Center for Genomic and Personalized Medicine, F 76000 Rouen, France
| | - C Monzo
- Institute for Neurosciences of Montpellier, Univ Montpellier, INSERM U1298, Montpellier, France
| | - E Schob
- Institute for Neurosciences of Montpellier, Univ Montpellier, INSERM U1298, Montpellier, France
| | - F Andreux
- Institute for Neurosciences of Montpellier, Univ Montpellier, INSERM U1298, Montpellier, France
| | - C Quittet
- Institute for Neurosciences of Montpellier, Univ Montpellier, INSERM U1298, Montpellier, France
| | - S Lehmann
- Institute for Neurosciences of Montpellier, Univ Montpellier, INSERM U1298, Montpellier, France
| | - D Wallon
- Normandie Univ, UNIROUEN, INSERM U1245, Rouen University Hospital, Department of Neurology and CNR-MAJ, Normandy Center for Genomic and Personalized Medicine, F 76000 Rouen, France
| | - C Crozet
- Institute for Neurosciences of Montpellier, Univ Montpellier, INSERM U1298, Montpellier, France.
| |
Collapse
|
2
|
Provost CC, Auboyer L, Rovelet-Lecrux A, Monzo C, Schob E, Lehmann S, Wallon D, Crozet C. Establishment of induced pluripotent stem cells IRMBi005-A from a patient with sporadic Alzheimer's disease. Stem Cell Res 2023; 72:103216. [PMID: 37783001 DOI: 10.1016/j.scr.2023.103216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/05/2023] [Revised: 09/19/2023] [Accepted: 09/23/2023] [Indexed: 10/04/2023] Open
Abstract
Alzheimer's disease (AD) is a progressive neurological disorder and the most common form of dementia worldwide. Sporadic Alzheimer's disease (sAD) cases are the main forms, over 95% of AD cases, but still poorly understood. Thereby there is a crucial need to develop in vitro models for studying this multifactorial disorder. Here, we report the reprogramming of skin fibroblasts from a 57-years-old male donor. The new generated iPSC cell line has a normal karyotype and, is pluripotent since it demonstrates the ability to differentiate in vitro into the three germ layers. This iPSC line will be used to understand pathological mechanisms of sAD.
Collapse
Affiliation(s)
| | - L Auboyer
- Institute for Regenerative Medicine and Biotherapy (IRMB), Univ Montpellier, INSERM, CHU Montpellier, Montpellier, France
| | - A Rovelet-Lecrux
- Normandie Univ, UNIROUEN, INSERM U1245, Rouen University Hospital, Department of Genetics and CNR-MAJ, Normandy Center for Genomic and Personalized Medicine, F 76000 Rouen, France
| | - C Monzo
- INM, Univ Montpellier, INSERM, Montpellier, France
| | - Eliot Schob
- INM, Univ Montpellier, INSERM, Montpellier, France
| | - S Lehmann
- INM, Univ Montpellier, INSERM, Montpellier, France
| | - D Wallon
- Normandie Univ, UNIROUEN, INSERM U1245, Rouen University Hospital, Department of Neurology and CNR-MAJ, Normandy Center for Genomic and Personalized Medicine, F 76000 Rouen, France
| | - C Crozet
- INM, Univ Montpellier, INSERM, Montpellier, France; Institute for Regenerative Medicine and Biotherapy (IRMB), Univ Montpellier, INSERM, CHU Montpellier, Montpellier, France
| |
Collapse
|
3
|
Auboyer L, Monzo C, Wallon D, Rovelet-Lecrux A, Gabelle A, Gazagne I, Cacheux V, Lehmann S, Crozet C. Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene. Stem Cell Res 2019; 37:101438. [PMID: 31004935 DOI: 10.1016/j.scr.2019.101438] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/24/2018] [Revised: 04/05/2019] [Accepted: 04/12/2019] [Indexed: 11/24/2022] Open
Abstract
Induced pluripotent stem cells (iPSC) were generated from skin fibroblasts obtained from a 58 year-old woman suffering from Alzheimer's disease and carrying a D694N mutation on Amyloid precursor protein (APP). Fibroblasts were reprogrammed into iPSC using the integration-free Sendai Virus which allows the expression of the Yamanaka factors. Verification of their pluripotency was achieved by demonstrating the expression of pluripotency markers and their differentiation potential into the three primary germ layers. The cells have the corresponding mutation and present a normal karyotype. The reported APP-D694N iPSC line may be used to model and study human AD pathology in vitro.
Collapse
Affiliation(s)
- L Auboyer
- Institute for Regenerative Medicine and Biotherapy (IRMB), Montpellier, France
| | - C Monzo
- Institute for Regenerative Medicine and Biotherapy (IRMB), Montpellier, France
| | - D Wallon
- Normandie Univ, UNIROUEN, Inserm U1245, Rouen University Hospital, Department of Neurology and CNR-MAJ, Normandy Center for Genomic and Personalized Medicine, F 76000 Rouen, France
| | - A Rovelet-Lecrux
- Normandie Univ, UNIROUEN, Inserm U1245, Rouen University Hospital, Department of Genetics and CNR-MAJ, Normandy Center for Genomic and Personalized Medicine, F 76000 Rouen, France
| | - A Gabelle
- Institute for Regenerative Medicine and Biotherapy (IRMB), Montpellier, France; Hopital St Eloi, CHU Montpellier, 80 rue augustin Fliche, 30295 Montpellier, France; Université de Montpellier, UM, 163 Rue Auguste Broussonnet, 34090 Montpellier, France
| | - I Gazagne
- Hopital St Eloi, CHU Montpellier, 80 rue augustin Fliche, 30295 Montpellier, France
| | - V Cacheux
- Hopital St Eloi, CHU Montpellier, 80 rue augustin Fliche, 30295 Montpellier, France
| | - S Lehmann
- Institute for Regenerative Medicine and Biotherapy (IRMB), Montpellier, France; Hopital St Eloi, CHU Montpellier, 80 rue augustin Fliche, 30295 Montpellier, France; Université de Montpellier, UM, 163 Rue Auguste Broussonnet, 34090 Montpellier, France
| | - C Crozet
- Institute for Regenerative Medicine and Biotherapy (IRMB), Montpellier, France; Hopital St Eloi, CHU Montpellier, 80 rue augustin Fliche, 30295 Montpellier, France.
| |
Collapse
|
4
|
Relaño-Ginés A, Lehmann S, Brillaud E, Belondrade M, Casanova D, Hamela C, Vincent C, Poupeau S, Sarniguet J, Alvarez T, Arnaud JD, Maurel JC, Crozet C. Lithium as a disease-modifying agent for prion diseases. Transl Psychiatry 2018; 8:163. [PMID: 30135493 PMCID: PMC6105724 DOI: 10.1038/s41398-018-0209-4] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/06/2017] [Revised: 06/12/2018] [Accepted: 06/20/2018] [Indexed: 12/12/2022] Open
Abstract
Prion diseases still remain incurable despite multiple efforts to develop a treatment. Therefore, it is important to find strategies to at least reduce the symptoms. Lithium has been considered as a neuroprotective agent for years, and the objective of this preclinical study was to evaluate the efficacy of lithium delivered as a water-in-oil microemulsion (Aonys®). This delivery system allows using low doses of lithium and to avoid the toxicity observed in chronic treatments. C57BL/6J mice were intracranially inoculated with ME7 prion-infected brain homogenates and then were treated with lithium from day 90 post inoculation until their death. Lithium was administered at traditional doses (16 mg/kg/day) by the gavage route and at lower doses (40 or 160 µg/kg/day; Aonys®) by the rectal mucosa route. Low doses of lithium (Aonys®) improved the survival of prion-inoculated mice, and also decreased vacuolization, astrogliosis, and neuronal loss compared with controls (vehicle alone). The extent of the protective effects in mice treated with low-dose lithium was comparable or even higher than what was observed in mice that received lithium at the traditional dose. These results indicate that lithium administered using this innovative delivery system could represent a potential therapeutic approach not only for prion diseases but also for other neurodegenerative diseases.
Collapse
Affiliation(s)
- A. Relaño-Ginés
- 0000 0001 2097 0141grid.121334.6Institut de Médecine Régénératrice et de Biothérapie (I.M.R.B.), Physiopathologie, diagnostic et thérapie cellulaire des affections neurodégénératives—Institut National de la Santé et de la Recherche Médicale Université de Montpellier U1183 Centre Hospitalo, Universitaire de Montpellier, Montpellier, France ,grid.433120.7Institut de Génétique Humaine, Centre National de la Recherche Scientifique-UPR1142, Montpellier, France
| | - S. Lehmann
- 0000 0001 2097 0141grid.121334.6Institut de Médecine Régénératrice et de Biothérapie (I.M.R.B.), Physiopathologie, diagnostic et thérapie cellulaire des affections neurodégénératives—Institut National de la Santé et de la Recherche Médicale Université de Montpellier U1183 Centre Hospitalo, Universitaire de Montpellier, Montpellier, France ,grid.433120.7Institut de Génétique Humaine, Centre National de la Recherche Scientifique-UPR1142, Montpellier, France
| | - E. Brillaud
- Medesis Pharma SA, Avenue du Golf, Baillargues, France
| | - M. Belondrade
- grid.433120.7Institut de Génétique Humaine, Centre National de la Recherche Scientifique-UPR1142, Montpellier, France
| | - D. Casanova
- grid.433120.7Institut de Génétique Humaine, Centre National de la Recherche Scientifique-UPR1142, Montpellier, France
| | - C. Hamela
- grid.433120.7Institut de Génétique Humaine, Centre National de la Recherche Scientifique-UPR1142, Montpellier, France
| | - C. Vincent
- Medesis Pharma SA, Avenue du Golf, Baillargues, France
| | - S. Poupeau
- Medesis Pharma SA, Avenue du Golf, Baillargues, France
| | - J. Sarniguet
- Medesis Pharma SA, Avenue du Golf, Baillargues, France
| | - T. Alvarez
- 0000 0001 2097 0141grid.121334.6Etablissement Confiné d’Expérimentation BioCampus, Université Montpellier, Campus Triolet, Bâtiment 53, CECEMA, Montpellier, France
| | - J. D. Arnaud
- 0000 0001 2097 0141grid.121334.6Etablissement Confiné d’Expérimentation BioCampus, Université Montpellier, Campus Triolet, Bâtiment 53, CECEMA, Montpellier, France
| | - J. C. Maurel
- Medesis Pharma SA, Avenue du Golf, Baillargues, France
| | - C. Crozet
- 0000 0001 2097 0141grid.121334.6Institut de Médecine Régénératrice et de Biothérapie (I.M.R.B.), Physiopathologie, diagnostic et thérapie cellulaire des affections neurodégénératives—Institut National de la Santé et de la Recherche Médicale Université de Montpellier U1183 Centre Hospitalo, Universitaire de Montpellier, Montpellier, France ,grid.433120.7Institut de Génétique Humaine, Centre National de la Recherche Scientifique-UPR1142, Montpellier, France
| |
Collapse
|
5
|
Crozet C, Chauvin I, Barbot M, Rihet I, Chord Auger S. Étude d’impact des températures de transport sur la qualité des résultats d’analyse en immuno-hématologie. Transfus Clin Biol 2015. [DOI: 10.1016/j.tracli.2015.06.073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
6
|
Lefèvre T, d’Ivernois JF, De Andrade V, Crozet C, Lombrail P, Gagnayre R. What do we mean by multimorbidity? An analysis of the literature on multimorbidity measures, associated factors, and impact on health services organization. Rev Epidemiol Sante Publique 2014; 62:305-14. [DOI: 10.1016/j.respe.2014.09.002] [Citation(s) in RCA: 54] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2014] [Revised: 08/08/2014] [Accepted: 09/05/2014] [Indexed: 12/21/2022] Open
|
7
|
Crozet C, Hue L, Alphonse M, Sall N’diaye P, Frete F, D’Ivernois JF. Tableau de bord d’évaluation et de suivi du programme d’Éducation thérapeutique de la Mutualité sociale agricole. Rev Epidemiol Sante Publique 2013. [DOI: 10.1016/j.respe.2013.07.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
8
|
Abstract
Prion diseases are neurodegenerative disorders characterized by the accumulation of an abnormal prion protein named PrP(Sc). PrP(Sc) results from the post-translational conformational modification of the host-encoded protein PrP(C). To date there is no treatment for this inexorably fatal disease. Hence, a major focus of research consists in the identification of new molecules that could interfere with in vivo prion propagation. Promising therapeutic approaches to block the production of PrP(Sc) are based on PrP RNA interference, passive or active immunization, dominant negative inhibition of PrP(Sc) formation, as well as inhibition of interactions between PrP(Sc) and other cofactors. Although these anti-prion molecules can be directly administered in vivo, the process to produce and purify them in high quantity is often challenging and expensive. An alternative strategy consists in the development of gene therapy systems of delivery. Importantly, the diagnosis of prion disease in humans remains difficult and often leaves a short therapeutic window after the appearance of the first clinical signs. As serious damages to the brain generally occur before clinical symptoms manifest, an ideal therapeutic strategy must target not only the formation of toxic aggregates, but also the brain destruction already incurred. This could be achieved by combining gene therapy with cell therapy. In this review we have chosen to highlight the multiple targets and potential gene or cell replacement therapeutic approaches. This review also presents the evidence for the transplantation of stem cells as well as the combination of cell and gene therapy as promising strategies against prion diseases.
Collapse
Affiliation(s)
- A Relaño-Ginés
- Institut de Génétique Humaine, CNRS-UPR 1142, Montpellier Cedex 5, France
| | | | | | | | | |
Collapse
|
9
|
Albano MG, Crozet C, d'Ivernois JF. Analysis of the 2004-2007 literature on therapeutic patient education in diabetes: results and trends. Acta Diabetol 2008; 45:211-9. [PMID: 18633570 DOI: 10.1007/s00592-008-0044-9] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/25/2008] [Accepted: 05/09/2008] [Indexed: 10/21/2022]
Abstract
The purpose of this study is to identify the recent characteristics and the developments of therapeutic education in diabetes through an analysis of the international articles published from 2004 to 2007. Studies were selected from several databases: Medline, Embase, Eric, Cochrane central database, using the following keywords: diabetes, patient education, self management, programs. Two authors independently reviewed each study and selected the data using the same categories of analysis. Articles consistently related to patient education in diabetes (80 among 118) were included. The selected articles have been published in 43 scientific journals. The majority of them concern TPE for adult patients with type 2 diabetes. TPE is delivered in several structures and education to groups of patients represents the most widespread educational strategy mostly provided by a multiprofessional team. A total of 70% of the studies show the effectiveness of TPE based on bioclinical, educational, psychosocial, economical criteria. The problem of barriers to TPE concerns 21% of the studies we have analysed and most of the authors propose the implementation of specifically-designed TPE programs as strategy to overcome them. A large number of studies still assess the positive effects of TPE. Nowadays the problems of accessibility to TPE and the barriers to this practice have become a major issue for research.
Collapse
Affiliation(s)
- M G Albano
- Cattedra di Didattica della Medicina, Faculty of Medicine, University of Foggia, V. L. Pinto, 1, Foggia, Italy.
| | | | | |
Collapse
|
10
|
Benhaim T, Sinna R, Garson S, Boloorchi A, Crozet C, Robbe M. Abdomen pendulum et injections sous-cutanées: les complications. À propos de deux cas. ANN CHIR PLAST ESTH 2007; 52:211-7. [PMID: 17316950 DOI: 10.1016/j.anplas.2006.12.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2006] [Accepted: 12/15/2006] [Indexed: 11/21/2022]
Abstract
The authors present the complications due to subcutaneous injections on two patients suffering from morbid obesity with an abdomen pendulum. In the first case, injections of heparin of low molecular weight at curative dose, for treatment of a pulmonary embolism, have been complicated with a giant abdominal wall haematoma, the biggest ever reported. The initial treatment was insufficient so we had to practice a dermolipectomy to take off the haematoma of four litters. In the second case, insulin injections were complicated with cellulitis of the abdominal wall and a surgical treatment has been practiced in emergency. The first case reminds us the importance to change the sites of injections and to accommodate the dose, surgical treatment staying as simple as possible. The second case allows us to report a rare complication, not often published but known with obese patients. These two cases illustrate the importance of therapeutic education of the patient and the fact that a simple injection can be life threatening.
Collapse
Affiliation(s)
- T Benhaim
- Service de chirurgie plastique, reconstructrice et esthétique, hôpital Nord, CHU d'Amiens, Place Victor-Pauchet, 80000 Amiens, France.
| | | | | | | | | | | |
Collapse
|
11
|
Marchand C, Crozet C, Martin D, Robert JJ, d'Ivernois JF, Gagnayre R. [A concept mapping study of nutritional knowledge in diabetic children and their parents]. Rev Med Suisse 2007; 3:868-72. [PMID: 17514928] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
Abstract
This study describes, using concept mapping, the nature, organization of knowledge on nutrition and its evolution following therapeutic patient education program in 5 diabetic children (8 to 9 years old) and their mothers. Before the education session, mothers and children are highly knowledgeable about food. The organization of knowledge in children is conceptual and differs from that found in mothers which is based on problems solving. After education, new knowledge and new links between old and recent knowledge testify of learning. A comparison between the maps of children and their mother reveals similarities but also differences in their preoccupations. This research shows that using the preexisting knowledge networks of parents and children could contribute to improve their education on nutrition.
Collapse
Affiliation(s)
- C Marchand
- Université Paris, Center de Recherche en Nutrition Humaine-lle-de-France.
| | | | | | | | | | | |
Collapse
|
12
|
Cordier C, Bencsik A, Philippe S, Bétemps D, Ronzon F, Calavas D, Crozet C, Baron T. Transmission and characterization of bovine spongiform encephalopathy sources in two ovine transgenic mouse lines (TgOvPrP4 and TgOvPrP59). J Gen Virol 2006; 87:3763-3771. [PMID: 17098996 DOI: 10.1099/vir.0.82062-0] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Transgenic mice expressing the prion protein (PrP) of species affected by transmissible spongiform encephalopathies (TSEs) have recently been produced to facilitate experimental transmission of these diseases by comparison with wild-type mice. However, whilst wild-type mice have largely been described for the discrimination of different TSE strains, including differentiation of agents involved in bovine spongiform encephalopathy (BSE) and scrapie, this has been only poorly described in transgenic mice. Here, two ovine transgenic mouse lines (TgOvPrP4 and TgOvPrP59), expressing the ovine PrP (A136 R154 Q171) under control of the neuron-specific enolase promoter, were studied; they were challenged with brainstem or spinal cord from experimentally BSE-infected sheep (AA136 RR154 QQ171 and AA136 RR154 RR171 genotypes) or brainstem from cattle BSE and natural sheep scrapie. The disease was transmitted successfully from all of these sources, with a mean of approximately 300 days survival following challenge with material from two ARQ-homozygous BSE-infected sheep in TgOvPrP4 mice, whereas the survival period in mice challenged with material from the ARR-homozygous BSE-infected sheep was 423 days on average. It was shown that, in the two ovine transgenic mouse lines, the Western blot characteristics of protease-resistant PrP (PrPres) were similar, whatever the BSE source, with a low apparent molecular mass of the unglycosylated glycoform, a poor labelling by P4 monoclonal antibody and high proportions of the diglycosylated form. With all BSE sources, but not with scrapie, florid plaques were observed in the brains of mice from both transgenic lines. These data reinforce the potential of this recently developed experimental model for the discrimination of BSE from scrapie agents.
Collapse
Affiliation(s)
- C Cordier
- Agence Française de Sécurité Sanitaire des Aliments, 31 avenue Tony Garnier, 69364 Lyon cedex 07, France
| | - A Bencsik
- Agence Française de Sécurité Sanitaire des Aliments, 31 avenue Tony Garnier, 69364 Lyon cedex 07, France
| | - S Philippe
- Agence Française de Sécurité Sanitaire des Aliments, 31 avenue Tony Garnier, 69364 Lyon cedex 07, France
| | - D Bétemps
- Agence Française de Sécurité Sanitaire des Aliments, 31 avenue Tony Garnier, 69364 Lyon cedex 07, France
| | - F Ronzon
- Agence Française de Sécurité Sanitaire des Aliments, 31 avenue Tony Garnier, 69364 Lyon cedex 07, France
| | - D Calavas
- Agence Française de Sécurité Sanitaire des Aliments, 31 avenue Tony Garnier, 69364 Lyon cedex 07, France
| | - C Crozet
- Agence Française de Sécurité Sanitaire des Aliments, 31 avenue Tony Garnier, 69364 Lyon cedex 07, France
| | - T Baron
- Agence Française de Sécurité Sanitaire des Aliments, 31 avenue Tony Garnier, 69364 Lyon cedex 07, France
| |
Collapse
|
13
|
Cirillo T, Albano MG, Crozet C, d'Ivernois JF. [Knowledges and beliefs related to nutrition of obese and overweight patients subjects: a study in Southern Italy]. Rev Med Suisse 2006; 2:848-50, 852. [PMID: 16646367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/08/2023]
Abstract
303 obese and overweight south Italian patients (240 women and 63 men), volunteers to participate in a patient education programme delivered by the university hospital of Foggia, have fullfiled a 50 items true/false test exploring the knowledges and the beliefs on obesity, nutrition, physical activities. The majority of the subjects has both low socio economical status and education level. Women have better performed than men (p<0.005) and obese patients, better than overweight subjects (p<0.005). The more frequent mistakes have concerned items on nutrition, meanwhile a better performance has been observed with the items on beliefs.
Collapse
Affiliation(s)
- T Cirillo
- Centro di Pedagogia delle Scienze della Salute, Facoltà di Medicina, Università degli Studi di Foggia, Italia.
| | | | | | | |
Collapse
|
14
|
Abstract
The occurrence of the variant Creutzfeldt-Jakob disease (vCJD), related to bovine spongiform encephalopathy (BSE), raises the important question of the sources of human contamination. The possibility that sheep may have been fed with BSE-contaminated foodstuff raises the serious concern that BSE may now be present in sheep without being distinguishable from scrapie. Sensitive models are urgently needed given the dramatic consequences of such a possible contamination on animal and human health. We inoculated transgenic mice expressing the ovine PrP gene with a brain homogenate from sheep experimentally infected with BSE. We found numerous typical florid plaques in their brains. Such florid plaques are a feature of vCJD in humans and experimental BSE infection in macaques. Our observation represents the first description, after a primary infection, of this hallmark in a transgenic mouse model. Moreover, these mice appear to be a promising tool in the search for BSE in sheep.
Collapse
Affiliation(s)
- C Crozet
- Agence Française de Sécurité Sanitaire des Aliments (AFSSA), Unité de Virologie-ATNC, 31 Avenue Tony Garnier, 69364 Lyon, France.
| | | | | | | | | | | |
Collapse
|
15
|
Crozet C, Flamant F, Bencsik A, Aubert D, Samarut J, Baron T. Efficient transmission of two different sheep scrapie isolates in transgenic mice expressing the ovine PrP gene. J Virol 2001; 75:5328-34. [PMID: 11333913 PMCID: PMC114937 DOI: 10.1128/jvi.75.11.5328-5334.2001] [Citation(s) in RCA: 64] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
We produced transgenic mice expressing the sheep prion protein to obtain a sensitive model for sheep spongiform encephalopathies (scrapie). The complete open reading frame, with alanine, arginine, and glutamine at susceptibility codons 136, 154, and 171, respectively, was inserted downstream from the neuron-specific enolase promoter. A mouse line, Tg(OvPrP4), devoid of the murine PrP gene, was obtained by crossing with PrP knockout mice. Tg(OvPrP4) mice were shown to selectively express sheep PrP in their brains, as demonstrated in mRNA and protein analysis. We showed that these mice were susceptible to infection by sheep scrapie following intracerebral inoculation with two natural sheep scrapie isolates, as demonstrated not only by the occurrence of neurological signs but also by the presence of the spongiform changes and abnormal prion protein accumulation in their brains. Mean times to death of 238 and 290 days were observed with these isolates, but the clinical course of the disease was strikingly different in the two cases. One isolate led to a very early onset of neurological signs which could last for prolonged periods before death. Independently of the incubation periods, some of the mice inoculated with this isolate showed low or undetectable levels of PrPsc, as detected by both Western blotting and immunohistochemistry. The development of experimental scrapie in these mice following inoculation of the scrapie infectious agent further confirms that neuronal expression of the PrP open reading frame alone is sufficient to mediate susceptibility to spongiform encephalopathies. More importantly, these mice provide a new and promising tool for studying the infectious agents in sheep spongiform encephalopathies.
Collapse
Affiliation(s)
- C Crozet
- Unité de Virologie-ATNC, Agence Française de Sécurité Sanitaire des Aliments, Lyon, France.
| | | | | | | | | | | |
Collapse
|